Tower Research Capital (TRC)’s Ambipar Emergency Response AMBI Stock Holding History
Bought
Maintained
Sold
Other funds holding AMBI
CIEP
BBP
SGDR
SS
Tower Research Capital (TRC)'s AMBI Position: Q1 2025 in Review
Tower Research Capital (TRC) sold out of Ambipar Emergency Response (AMBI) in Q1 2025, closing a stake of 53 shares — an estimated $280 sold.
Tower Research Capital (TRC) first reported a position in AMBI in Q1 2023 and held it in 8 quarters. The position peaked at $514 in Q2 2023. 6 funds tracked by Wall St. Rank hold AMBI as of Q1 2025.
- Tower Research Capital (TRC) reported no remaining Ambipar Emergency Response position as of Q1 2025 after selling out during the quarter.
- Tower Research Capital (TRC) sold 53 Ambipar Emergency Response shares in Q1 2025, an estimated $280.
- Tower Research Capital (TRC) first reported a position in Ambipar Emergency Response in Q1 2023 and held it in 8 quarters.
- Tower Research Capital (TRC)'s Ambipar Emergency Response position peaked at $514 in Q2 2023.
- 6 funds tracked by Wall St. Rank held Ambipar Emergency Response as of Q1 2025.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.